Actively Recruiting
Peripheral Drivers of Heart Failure Progression - The Prospective PEDAL-HF Study
Led by University of Leipzig · Updated on 2026-05-06
1000
Participants Needed
1
Research Sites
213 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
PEDAL-HF is a registry-based randomized prospective multicenter study. The investigators plan to include 1000 patients who were recently admitted with acute decompensated heart failure at five tertiary heart clinics in Germany. For the randomised part, 750 patients will be randomized to care within a heart failure network or usual care. The primary endpoint of the randomized trial is change in NT-proBNP from baseline to 6 months of follow-up. All patients (randomized or not) will be followed for two years.
CONDITIONS
Official Title
Peripheral Drivers of Heart Failure Progression - The Prospective PEDAL-HF Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients admitted to the participating study centres with acute decompensated heart failure (ADHF), defined as clinical signs and/or symptoms of heart failure
- Objective structural cardiac abnormalities according to the ESC criteria
- Age 18 years or older
You will not qualify if you...
- Age under 18 years
- Pregnancy
- Any condition interfering with the informed consent process
- Patients placed in an institution by official or court order
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital Leipzig
Leipzig, Germany
Actively Recruiting
Research Team
R
Rolf Wachter, MD
CONTACT
S
Sophie Charlotte Schröder, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here